Kristie L. Kahl

Preliminary findings showed that Revlimid (lenalidomide) significantly prolonged progression-free survival compared with observation in patients with smoldering multiple myeloma.

A blood test may help to identify a subset of patients with mantle cell lymphoma and determine the management of outcomes of these individuals.

After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.

In a recent survey, individuals in remission reported a more positive experience with bladder cancer compared with their counterparts who currently have active disease.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.

One family shares their experience with the discovery of a BRCA mutation, and how they discussed it among one another.

Exercise and nutrition are essential to improving a variety of facets revolving around the continuum of cancer — from prevention to diagnosis and treatment to survivorship care.

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Imagine receiving two pieces of life-altering news in a matter of three days. One survivor not only experienced this, but came out the other side with a positive outlook and a humorous book, too.

In this episode of CURE Talks Cancer, we caught up with all three storytellers from the “Our Way Forward: Stories that Illuminate the Ovarian Cancer Experience,” storytelling event hosted through a special engagement with The Moth.

As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.

The amount of preventative medicines given during hospital admission may be associated with an increased amount prescribed at discharge – resulting in higher costs and an increased risk for drug-drug interactions in patients with advanced lung cancer.

In the first such clinical trial in the United States, researchers will evaluate focused ultrasound to breach the blood-brain barrier

The National Comprehensive Cancer Network updated its Clinical Practice Guidelines to add two new options for the frontline treatment of patients with kidney cancer.

In this week’s special edition of CURE Talks Cancer, we spoke with Bravo TV’s “Real Housewives of Beverly Hills” star Camille Grammer about her experience with uterine cancer, and the advocacy work she does for “below the belt” cancers.

Alejandra Campoverdi shares her experience with having a BRCA2 mutation and explains how the Well Women Coalition is helping to start the conversation among women of color across the country.

Eleven years ago, Stephanie Hosford received two pieces of life-changing news within the span of three days: she was diagnosed with triple-negative breast cancer and she found out she was pregnant – all while going through an adoption process at the same time.

In this special edition of the CURE Talks Cancer podcast, we kick off National Hereditary Breast and Ovarian Cancer Week and Previvor Day.

Researchers determined that the use of methotrexate, vinblastine, doxorubicin and cisplatin before cystectomy may induce better outcomes for patients with advanced bladder cancer.

A recent study from St. Jude Children’s Hospital found that more than half of adults who survived pediatric central nervous system tumors failed to achieve independence as adults.

The IMpower133 trial demonstrated the added overall and progression-free survival benefits of adjuvant Tecentriq with standard of care therapy for patients with extensive-stage small cell lung cancer.

In a recent survey, lung cancer survivors reported long-term symptoms, including shortness of breath, fatigue, short-term memory and anxiety.

Patient-caregiver communities focused on non-small cell lung cancer with genomic alterations offer support, awareness and education to help accelerate research in this space.

“Key brain regions that we know are typically involved in autobiographical memory formation and retrieval, especially the hippocampus, are located quite far from the primary tumor bed, and thus far from the site of focal radiation,” Sekeres, who is director of the Sekeres Memory Laboratory at Baylor University, said in an interview with CURE.

In this episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, vice president of strategic communications and development at the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research of head and neck cancer.

A recent study showed that socioeconomic status may explain racial and ethnic disparities found among childhood cancer survivors of certain cancers.

Nicholas J. Vogelzang, M.D., FASCO, FACP, has seen cancer through a variety of lenses – from oncologist to patient as well as caregiver – giving him a different perspective than most.

A study published in Blood demonstrated the significant disparities found between insurance status and survival outcomes in patients of all ages with follicular lymphoma.

The Food and Drug Administration (FDA) granted priority review to Keytruda (pembrolizumab) monotherapy for the first-line treatment of patients with locally advanced or metastatic nonsquamous or squamous non-small cell lung cancer (NSCLC) whose tumors express PD-L1 without EGFR or ALK genomic tumor aberrations.